Masters in Thoracic Oncology Summit (MaTOS)
Through open discussions we will have the opportunity to analyze the latest discoveries in genetics and epigenomics in lung cancer, including diagnosis, minimal residual disease (MRD), monitoring for recurrence, and assessment of therapeutic success with targeted therapy and immunotherapy.